Genmab A/S
AXL ANTIBODY-DRUG CONJUGATES FOR USE IN TREATING CANCER

Last updated:

Abstract:

The present invention relates to conjugates of antibodies and cytotoxic agents for use in treatment of cancer in combination with an inhibitor of PD-1 or PD-L1. The antibodies are directed against Axl.

Status:
Application
Type:

Utility

Filling date:

17 Jul 2020

Issue date:

1 Sep 2022